Modification, Biological Evaluation and SAR Studies of Novel 1H -Pyrazol Derivatives Containing N ,N ′-Disubstituted Urea Moiety as Potential Anti-melanoma Agents-Reference-Cited by-同舟云学术

Modification, Biological Evaluation and SAR Studies of Novel 1H -Pyrazol Derivatives Containing N ,N ′-Disubstituted Urea Moiety as Potential Anti-melanoma Agents

Published:2018-05-18 Issue:6 Volume:15 Page:e1700504
ISSN:1612-1872
Container-title:Chemistry & Biodiversity
language:en
Short-container-title:Chem. Biodiversity

Author:

Ruan Ban-Feng¹,Lin Meng-Xue¹,Shao Qin¹,Wang Tian-Hong¹,Zhang Qing¹,Dong Yu-Lu¹,Bu Chao-Nan¹,Xu Hua-Jian¹,Zhou Ben-Guo²,Li Qing-Shan¹

Affiliation:

1. School of Biological and Medical Engineering; Hefei University of Technology; Hefei 230009 P. R. China

2. Tobacco Research Institute; Anhui Academy of Agricultural Sciences; Hefei 230031 P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Anhui Province

Fundamental Research Funds for the Central Universities

Key Scientific and Technological Project of Anhui Provincial Tobacco Company

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Reference23 articles.

1. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation;Chapman;New. Engl. J. Med.,2011

2. The Malignant Melanoma Landscape;Webster;Nat. Rev. Drug Discovery,2014

3. Which Drug, and When, for Patients with BRAF-Mutant Melanoma?;Jang;Lancet Oncol.,2013

4. MAP Kinases;Chen;Chem. Rev.,2001

5. Towards the Development of Chromone-Based MEK1/2 Modulators;Redwan;Eur. J. Med. Chem.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated literature on BRAF inhibitors (2018–2023);Molecular Diversity;2023-07-20

2. Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents;Bioorganic Chemistry;2021-09

3. Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: Discovery of potent and selective agents for ovarian cancer;Bioorganic & Medicinal Chemistry;2021-01

4. Systemic review on B-RafV600E mutation as potential therapeutic target for the treatment of cancer;European Journal of Medicinal Chemistry;2020-11